ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Tc-99m DMSA Uptake by Metastatic Colorectal Carcinoma
Clinical Nuclear Medicine
◽
10.1097/01.rlu.0000132948.44939.81
◽
2004
◽
Vol 29
(8)
◽
pp. 485-487
◽
Cited By ~ 6
Author(s):
Phivi Rondogianni
◽
George Koniaris
Keyword(s):
Colorectal Carcinoma
◽
Metastatic Colorectal Carcinoma
Download Full-text
Related Documents
Cited By
References
Treatment with standardized mistletoe extract (Viscum album L.) Iscador® as a part of long-term supportive care in patients with primary non-metastatic colorectal carcinoma
Zeitschrift für Gastroenterologie
◽
10.1055/s-2007-988193
◽
2007
◽
Vol 45
(08)
◽
Author(s):
E Friedel
◽
H Matthes
◽
P Bock
Keyword(s):
Colorectal Carcinoma
◽
Supportive Care
◽
Viscum Album
◽
Metastatic Colorectal Carcinoma
◽
Mistletoe Extract
Download Full-text
Metastatic colorectal carcinoma in a 76-year old male: a pitfall in the diagnosis of unclassified renal cell carcinoma
10.26226/morressier.5b4709866f4cb3001095184e
◽
2018
◽
Author(s):
Dafne Carvalho Andrade
Keyword(s):
Renal Cell Carcinoma
◽
Colorectal Carcinoma
◽
Cell Carcinoma
◽
Renal Cell
◽
Metastatic Colorectal Carcinoma
Download Full-text
Faculty Opinions recommendation of Final analysis of the randomised PEAK trial: overall survival and tumour responses during first-line treatment with mFOLFOX6 plus either panitumumab or bevacizumab in patients with metastatic colorectal carcinoma.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.727549021.793550895
◽
2018
◽
Author(s):
Sebastian Stintzing
Keyword(s):
Overall Survival
◽
Colorectal Carcinoma
◽
Final Analysis
◽
Line Treatment
◽
Metastatic Colorectal Carcinoma
◽
First Line
◽
First Line Treatment
Download Full-text
Influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab or cetuximab as first-line therapy in patients with RAS wild-type metastatic colorectal carcinoma and <3 baseline circulating tumour cells: the randomised phase II VISNÚ-2 study
ESMO Open
◽
10.1016/j.esmoop.2021.100062
◽
2021
◽
Vol 6
(2)
◽
pp. 100062
Author(s):
J. Sastre
◽
P. García-Alfonso
◽
J.M. Viéitez
◽
M.T. Cano
◽
F. Rivera
◽
...
Keyword(s):
Colorectal Carcinoma
◽
Phase Ii
◽
Tumour Cells
◽
Circulating Tumour Cells
◽
Wild Type
◽
Metastatic Colorectal Carcinoma
◽
First Line
◽
Pik3ca Mutations
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Serum Retinol, Alpha-Tocopherol and Systemic Inflammatory Response in Metastatic Colorectal Carcinoma Patients Treated with Combination Chemotherapy and Cetuximab
Journal of Nutritional Science and Vitaminology
◽
10.3177/jnsv.56.222
◽
2010
◽
Vol 56
(4)
◽
pp. 222-226
◽
Cited By ~ 10
Author(s):
Bohuslav MELICHAR
◽
Lenka KRCMOVÁ
◽
Hana KALÁBOVÁ
◽
Petra HOLECKOVÁ
◽
Markéta KASPAROVÁ
◽
...
Keyword(s):
Colorectal Carcinoma
◽
Inflammatory Response
◽
Combination Chemotherapy
◽
Systemic Inflammatory Response
◽
Alpha Tocopherol
◽
Metastatic Colorectal Carcinoma
◽
Serum Retinol
Download Full-text
Surgical downstaging and neo-adjuvant therapy in metastatic colorectal carcinoma with irinotecan drug-eluting beads: a multi-institutional study
HPB
◽
10.1111/j.1477-2574.2009.00117.x
◽
2010
◽
Vol 12
(1)
◽
pp. 31-36
◽
Cited By ~ 33
Author(s):
Matthew Bower
◽
Tiffany Metzger
◽
Ken Robbins
◽
Dana Tomalty
◽
Vlatimil Válek
◽
...
Keyword(s):
Adjuvant Therapy
◽
Colorectal Carcinoma
◽
Metastatic Colorectal Carcinoma
◽
Drug Eluting Beads
◽
Drug Eluting
Download Full-text
Baseline carcinoembryonic antigen as a predictive factor of ramucirumab efficacy in RAISE, a second-line metastatic colorectal carcinoma phase III trial
European Journal of Cancer
◽
10.1016/j.ejca.2017.03.007
◽
2017
◽
Vol 78
◽
pp. 61-69
◽
Cited By ~ 15
Author(s):
Takayuki Yoshino
◽
Radka Obermannová
◽
György Bodoky
◽
Rocio Garcia-Carbonero
◽
Tudor Ciuleanu
◽
...
Keyword(s):
Colorectal Carcinoma
◽
Carcinoembryonic Antigen
◽
Predictive Factor
◽
Phase Iii
◽
Second Line
◽
Metastatic Colorectal Carcinoma
◽
Phase Iii Trial
Download Full-text
The Randomized Phase 3 Impala Study: Immunomodulatory Maintenance Therapy with TLR-9 Agonist MGN1703 in Patients with Metastatic Colorectal Carcinoma
Annals of Oncology
◽
10.1093/annonc/mdu165.263
◽
2014
◽
Vol 25
◽
pp. ii98
Author(s):
Cunningham David
◽
Zurlo Alfredo
◽
Salazar Ramon
◽
Ducreux Michel
◽
Waddell Tom
◽
...
Keyword(s):
Colorectal Carcinoma
◽
Maintenance Therapy
◽
Metastatic Colorectal Carcinoma
◽
Phase 3
Download Full-text
A Phase I Study of Cisplatinum plus 5-Fluorouracil in Modulation with Citrovorum Factor in Metastatic Colorectal Carcinoma
Journal of Chemotherapy
◽
10.1080/1120009x.1991.11739087
◽
1991
◽
Vol 3
(3)
◽
pp. 170-175
◽
Cited By ~ 1
Author(s):
S. Palmeri
◽
V. Gebbia
◽
A. Russo
◽
N. Gebbia
◽
Y. Rustum
◽
...
Keyword(s):
Colorectal Carcinoma
◽
Phase I
◽
Phase I Study
◽
Metastatic Colorectal Carcinoma
Download Full-text
A phase II study of the modulation of 5-fluorouracil and folinic acid with high-dose infusional hydroxyurea in metastatic colorectal carcinoma
Annals of Oncology
◽
10.1023/a:1008330302535
◽
1999
◽
Vol 10
(8)
◽
pp. 981-983
◽
Cited By ~ 5
Author(s):
K.J. O'Byrne
◽
P.A. Philip
◽
D.J. Propper
◽
I.P. Braybrooke
◽
M.P. Saunders
◽
...
Keyword(s):
Colorectal Carcinoma
◽
Folinic Acid
◽
Phase Ii
◽
Phase Ii Study
◽
High Dose
◽
Metastatic Colorectal Carcinoma
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close